joint diseases
Genomics PLC to Provide Polygenic Risk Scores for UK's Our Future Health Research Program
The company will work in partnership with Our Future Health to generate risk scores for up to 5 million people and to create methods for providing feedback to participants.
BioMérieux Joint Infection Panel Gets FDA De Novo Authorization
The 39-target panel runs on FilmArray systems and tests for 31 pathogens implicated in most acute joint infections as well as eight antimicrobial resistance genes.
Carpal Tunnel GWAS Highlights Growth-Related Loci, Genetic Ties to Height
A genome-wide association study involving more than 12,300 carpal tunnel syndrome patients and controls from the UK Biobank led to 16 genetic loci.
Although SUNY and NYU's financial stake in the proceedings is unclear, they are seeking to protect a royalty stream that dates back to a 1992 licensing agreement with Galderma predecessor Collagenix Pharmaceuticals for some of the patents protecting Oracea, which exceeded $50 million in sales in 2007.
Kauffman Foundation, MIT, BioAMPS, University of Colorado, Endo Pharma, Harvard, Galapagos, Flanders Institute of Biotechnology, and more …